Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

Severe abdominal pains, unpredictable bowel movements and fatigue are some of the serious symptoms 180,000 Australians live ...

Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Inflammatory bowel disease (IBD) is a term that encompasses two chronic diseases of the gastrointestinal tract—ulcerative colitis and Crohn's disease. Symptoms of both forms of IBD overlap and include ...

Introduction Studies describing the epidemiology of inflammatory bowel disease (IBD) in the UK have been limited by small sample size and low generalisability. We describe temporal trends in the ...

Iterative Health will present five abstracts at the European Crohn’s & Colitis Organization (ECCO) meeting in Berlin, Germany ...

Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel disease. An analysis of almost 40,000 patients showed differences in age, ...